Kezar Life Sciences, Inc. (KZR)
7.29
0.00 (0.00%)
USD |
NASDAQ |
Aug 21, 16:00
Kezar Life Sciences Total Liabilities (Quarterly) : 2.762M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 2.762M |
| December 31, 2025 | 6.574M |
| September 30, 2025 | 14.75M |
| June 30, 2025 | 17.34M |
| March 31, 2025 | 22.19M |
| December 31, 2024 | 27.77M |
| September 30, 2024 | 30.04M |
| June 30, 2024 | 29.24M |
| March 31, 2024 | 30.01M |
| December 31, 2023 | 33.66M |
| September 30, 2023 | 33.33M |
| June 30, 2023 | 31.10M |
| March 31, 2023 | 31.69M |
| December 31, 2022 | 29.70M |
| September 30, 2022 | 21.58M |
| June 30, 2022 | 20.14M |
| March 31, 2022 | 19.55M |
| Date | Value |
|---|---|
| December 31, 2021 | 21.06M |
| September 30, 2021 | 11.41M |
| June 30, 2021 | 9.786M |
| March 31, 2021 | 11.70M |
| December 31, 2020 | 10.86M |
| September 30, 2020 | 10.89M |
| June 30, 2020 | 10.00M |
| March 31, 2020 | 11.99M |
| December 31, 2019 | 11.47M |
| September 30, 2019 | 11.03M |
| June 30, 2019 | 10.66M |
| March 31, 2019 | 10.91M |
| December 31, 2018 | 5.885M |
| September 30, 2018 | 6.14M |
| June 30, 2018 | 6.33M |
| March 31, 2018 | 6.809M |
| December 31, 2017 | 1.978M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| NovelStem International Corp. | 2.097M |
| Brainstorm Cell Therapeutics, Inc. | 12.38M |
| Summit Therapeutics, Inc. | 122.20M |
| Protara Therapeutics, Inc. | 14.78M |
| Clene, Inc. | 47.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 68.00M |
| Shareholders Equity (Quarterly) | 65.24M |
| Debt to Equity Ratio | 0.0208 |
| Current Ratio | 24.46 |
| Net Debt Paydown Yield | 5.42% |